Acorda Therapeutics Inc. (ACOR) announced late Friday afternoon that the U.S. Patent and Trademark Office Patent Trials and Appeal Board has instituted the inter partes review of 4 patents related to Ampyra. A ruling is expected to be reached within 1 year.
from RTT - Before the Bell http://ift.tt/1MhEDQL
via IFTTT
No comments:
Post a Comment